| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.87M | - | |
| Dir | 164.0K | $12.52M | -8,000 | |
| VP | 100.3K | $7.66M | - | |
| VP | 83.3K | $6.36M | -60,846 | |
| CFO | 82.7K | $6.31M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2023 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sell | 1,813 | $40.57 | $73,560.30 | -2.5% | -13.1% | +21.3% | |
| Feb 6, 2023 | Monia Brett P60 | Chief Executive Officer | Sell | 24,651 | $40.69 | $1,003,152.72 | -14.5% | -13.1% | +21.3% | |
| Jan 31, 2023 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sell | 9,000 | $39.56 | $356,071.95 | -9.7% | -10.5% | +28.9% | |
| Jan 18, 2023 | Swayze Eric63 | EVP Research | Sale+OE | 5,631 | $39.74 | $223,799.59 | -15.8% | -8.6% | +27.2% | |
| Jan 18, 2023 | Schneider Eugene64 | EVP, Chf Clinical Develop Ofcr | Sale+OE | 4,752 | $39.57 | $188,051.85 | -17.5% | -8.6% | +27.2% | |
| Jan 18, 2023 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 7,836 | $39.49 | $309,479.69 | -13.9% | -8.6% | +27.2% | |
| Jan 18, 2023 | Monia Brett P60 | Chief Executive Officer | Sale+OE | 25,066 | $39.49 | $989,946.58 | -17.2% | -8.6% | +27.2% | |
| Jan 18, 2023 | Hougen Elizabeth L55 | EVP, Finance &CFO | Sale+OE | 8,280 | $39.70 | $328,720.97 | -10.1% | -8.6% | +27.2% | |
| Jan 18, 2023 | Geary Richard S65 | EVP, Chief Development Officer | Sale+OE | 7,873 | $39.57 | $311,525.16 | -10.0% | -8.6% | +27.2% | |
| Jan 18, 2023 | Cadoret-Manier Onaiza53 | EVP, Chf Gl Pdt Str &Oper Ofc | Sale+OE | 3,748 | $39.55 | $148,223.28 | -16.8% | -8.6% | +27.2% |